DNA Vaccine-Encoded Flagellin Can Be Used As an Adjuvant Scaffold to Augment HIV-1 Gp41 Membrane Proximal External Region Immunogenicity

DNA Vaccine-Encoded Flagellin Can Be Used As an Adjuvant Scaffold to Augment HIV-1 Gp41 Membrane Proximal External Region Immunogenicity

viruses Article DNA Vaccine-Encoded Flagellin Can Be Used as an Adjuvant Scaffold to Augment HIV-1 gp41 Membrane Proximal External Region Immunogenicity Lara Ajamian 1,2, Luca Melnychuk 1,2, Patrick Jean-Pierre 1 and Gerasimos J. Zaharatos 1,3,* ID 1 Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC H3T 1E2, Canada; [email protected] (L.A.); [email protected] (L.M.); [email protected] (P.J.-P.) 2 Division of Experimental Medicine, Department of Medicine, McGill University, Montréal, QC H4A 3J1, Canada 3 Division of Infectious Disease, Department of Medicine & Division of Medical Microbiology, Department of Clinical Laboratory Medicine, Jewish General Hospital, Montréal, QC H3T 1E2, Canada * Correspondence: [email protected]; Tel.: +1-514-340-8294 Received: 28 January 2018; Accepted: 23 February 2018; Published: 27 February 2018 Abstract: Flagellin’s potential as a vaccine adjuvant has been increasingly explored over the last three decades. Monomeric flagellin proteins are the only known agonists of Toll-like receptor 5 (TLR5). This interaction evokes a pro-inflammatory state that impacts upon both innate and adaptive immunity. While pathogen associated molecular patterns (PAMPs) like flagellin have been used as stand-alone adjuvants that are co-delivered with antigen, some investigators have demonstrated a distinct advantage to incorporating antigen epitopes within the structure of flagellin itself. This approach has been particularly effective in enhancing humoral immune responses. We sought to use flagellin as both scaffold and adjuvant for HIV gp41 with the aim of eliciting antibodies to the membrane proximal external region (MPER). Accordingly, we devised a straightforward step-wise approach to select flagellin-antigen fusion proteins for gene-based vaccine development. Using plasmid DNA vector-based expression in mammalian cells, we demonstrate robust expression of codon-optimized full length and hypervariable region-deleted constructs of Salmonella enterica subsp. enterica serovar Typhi flagellin (FliC). An HIV gp41 derived sequence including the MPER (gp41607–683) was incorporated into various positions of these constructs and the expressed fusion proteins were screened for effective secretion, TLR5 agonist activity and adequate MPER antigenicity. We show that incorporation of gp41607–683 into a FliC-based scaffold significantly augments gp41607–683 immunogenicity in a TLR5 dependent manner and elicits modest MPER-specific humoral responses in a mouse model. Keywords: HIV-1; gp41; membrane proximal external region; MPER; flagellin; adjuvant; DNA vaccine 1. Introduction Despite the tremendous success generated by an empiric approach to vaccine development, eliciting robust and long-lasting protective immunity to certain pathogens remains challenging [1,2]. While live attenuated virus vaccines have remarkable efficacy, this is not a solution for all pathogens either because they cannot be safely attenuated or because natural infection does not confer protective immunity [2–9]. Purified protein or recombinant subunit vaccines have provided a way forward in some instances, however the immunogenicity of such antigens is often poor or vaccination simply does not generate the type of immune response required for protection [10,11]. In some instances, the magnitude, longevity or quality of the immune response to such antigens has been improved by using adjuvants, however the mechanism of adjuvant function has been ill-defined for most adjuvants [10,11]. Viruses 2018, 10, 100; doi:10.3390/v10030100 www.mdpi.com/journal/viruses Viruses 2018, 10, 100 2 of 23 Viruses 2018, 10, x 2 of 23 does not generate the type of immune response required for protection [10,11]. In some instances, the The discovery of pathogen associated molecular patterns (PAMPs), particularly ligands for magnitude, longevity or quality of the immune response to such antigens has been improved by Toll-likeusing receptors adjuvants, (TLRs) however have the revolutionized mechanism of our adju understandingvant function has of innatebeen ill-defined immunity for and most ushered in aadjuvants new era [10,11]. of rational adjuvant development [10,12,13]. One promising avenue of adjuvant research hasThe stemmeddiscovery of from pathogen work associated with the molecular Toll-like receptorpatterns (PAMPs), 5 (TLR5) particularly ligand flagellin. ligands Polymerizedfor Toll- flagellinlike receptors proteins (TLRs) are the have major revolutionized component our ofunderstanding the flagellar of apparatusinnate immunity of motile and ushered gram-negative in a and gram-positivenew era of rational bacteria adjuvant [14 development]. Monomeric [10,12,13]. flagellin One promising proteins avenue are the of onlyadjuvant known research agonists has of TLR5stemmed [15] and from a large work body with ofthe workToll-like has receptor explored 5 (TLR5) the interaction ligand flagellin. between Polymerized the major flagellinSalmonella flagellinproteins protein, are the FliC major and component TLR5 [16– 22of]. the TLR5 flagella is expressedr apparatus on of a motile variety gram-negative of cells including and gram- epithelial positive bacteria [14]. Monomeric flagellin proteins are the only known agonists of TLR5 [15] and a cells, monocytes and dendritic cells [21,23]. Flagellin interacts with TLR5 on the cell surface in large body of work has explored the interaction between the major Salmonella flagellin protein, FliC a 2:2 complex and induces dimerization of flagellin-TLR5 pairs [24,25]. The resulting dimerization and TLR5 [16–22]. TLR5 is expressed on a variety of cells including epithelial cells, monocytes and of thedendritic intracellular cells [21,23]. TIR domains Flagellin interacts of TLR5 with activate TLR5 downstreamon the cell surface signaling in a 2:2 pathways. complex and This induces includes a MyD88-dependentdimerization of flagellin-TLR5 signalling cascadepairs [24,25]. that culminatesThe resulting in dimerization the induction of the of transcriptionintracellular TIR factors, includingdomains NF- ofκB[ TLR516–22 activate,26]. In downstream turn, these transcriptionsignaling pathways. factors This upregulate includes cytokine a MyD88-dependent transcription and ultimatelysignalling evoke cascade a pro-inflammatory that culminates in state. the induction of transcription factors, including NF-κB [16– Flagellin22,26]. In turn, that gainsthese transcription access to the factors cytosol upregula is alsote acytokine trigger transcription for the NAIP–NLRC4 and ultimately inflammasome, evoke a wherepro-inflammatory flagellin is sensed state. by the cytosolic receptor, NAIP5/6 and provokes its interaction with the adapter protein,Flagellin NLRC4that gains [ 27access–35]. to Thisthe cytosol cascade is also triggers a trigger inflammasome for the NAIP–NLRC4 assembly inflammasome, and subsequent where flagellin is sensed by the cytosolic receptor, NAIP5/6 and provokes its interaction with the caspase-1 activation [32,34–37]. Activated caspase-1 processes several pro-inflammatory cytokines adapter protein, NLRC4 [27–35]. This cascade triggers inflammasome assembly and subsequent including pro-IL1β and pro-IL-18, thus promoting secretion of their biologically active forms. caspase-1 activation [32,34–37]. Activated caspase-1 processes several pro-inflammatory cytokines Flagellinincluding pro-IL1 has a four-domainβ and pro-IL-18, structure thus promoting [14,21, 38secretio], whereinn of their domains biologically D0 active and D1 forms. are formed by interactionFlagellin between has the a four-domain N-terminal andstructure C-terminal [14,21,38] portions, wherein of thedomains protein D0 thusand producingD1 are formed a stalk-like by structureinteraction with between a concave the surface.N-terminal The and central C-terminal domains portions D2 of andthe protein D3 form thus a producing cluster emanating a stalk- at an anglelike structure from this with stalk a concave (Figure surface.1). The The N and central C-termini domains are D2 criticaland D3 form to flagellin a cluster polymerization emanating at an and certainangle residue from stretchesthis stalk are(Figure highly 1). The conserved N and C-termini among β areand criticalγ Proteobacteria to flagellin, whereaspolymerization the D2 and and D3 domainscertain are residue highly stretches variable are among highly different conserved bacteria among β [21 and,39 γ]. Proteobacteria Conserved, stretcheswhereas the of theD2 and D1 domainD3 containsdomains the key are residueshighly variable engaging among with different TLR5 andbacteria remain [21,39]. sequestered Conserved from stretches immune of the selective D1 domain pressure contains the key residues engaging with TLR5 and remain sequestered from immune selective while flagellin is in a polymerized state [24,40–43]. The C-terminal portion of the D0 domain is also pressure while flagellin is in a polymerized state [24,40–43]. The C-terminal portion of the D0 domain highly conserved and is essential for NAIP-NLRC4 inflammasome triggering [27,32,44]. Conversely, is also highly conserved and is essential for NAIP-NLRC4 inflammasome triggering [27,32,44]. the hypervariableConversely, the region hypervariable is exposed region on theis exposed outside on surface the outside of the surface flagellar of the apparatus flagellar apparatus and is a dominant and targetis fora dominant humoral target responses for humoral [42,45 responses–47]. [42,45–47]. FigureFigure 1. Domain 1. Domain structure structure offull-length of full-length

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    23 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us